🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Surviving Pneumonia

Recruitingn/aAges 18 Years - anyAllNordsjaellands Hospital
NCT03795662 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The study aims to explore risk factors for poor prognosis among patients admitted with community-acquired pneumonia (CAP). During a 5-year study period, all patients (aged ≥ 18 years) admitted with CAP at North Zealand Hospital will be invited for inclusion. Questionnaires, anthropometric measures, laboratory tests, and biomaterials will be collected at admission, daily during admission, at discharge and at follow-up. The main clinical outcomes of the study consist of deaths and development of diabetes.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Infiltrate on chest radiograph plus one or more of the following: * Fever (temperature, ≥38.0°C) * Hypothermia (\<35.0°C), * New cough with or without sputum production * Pleuritic chest pain * Dyspnea * Altered breath sounds on auscultation. Exclusion Criteria: * Patients unable to give informed consent * Patients unwilling to give informed consent
💊

What it tests

  • No intervention
📍

Where

1 site
Department of Pulmonary and Infectious Diseases, Nordsjællands Hospital
Hillerød, Denmark
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy